Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014;18(8):438.
doi: 10.1007/s11916-014-0438-z.

Trigeminal autonomic cephalalgias: beyond the conventional treatments

Affiliations
Review

Trigeminal autonomic cephalalgias: beyond the conventional treatments

Sarah Miller et al. Curr Pain Headache Rep. 2014.

Abstract

The trigeminal autonomic cephalalgias include cluster headache, paroxysmal hemicrania, short-lasting unilateral neuralgiform headache attacks, and hemicrania continua. While the majority responds to conventional pharmacological treatments, a small but significant proportion of patients are intractable to these treatments. In these cases, alternative choices for these patients include oral and injectable drugs, lesional or resectional surgery, and neurostimulation. The evidence base for conventional treatments is limited, and the evidence for those used beyond convention is more so. At present, the most evidence exists for nerve blocks, deep brain stimulation, occipital nerve stimulation, sphenopalatine ganglion stimulation in chronic cluster headache, and microvascular decompression of the trigeminal nerve in short-lasting unilateral neuralgiform headache attacks.

PubMed Disclaimer

Conflict of interest statement

Dr. Sarah Miller has received educational grants from St Jude Medical, educational and travel grants from Medtronic, and speaker’s fees for Allergen.

Dr. Manjit Matharu serves on the advisory board for Allergan and St Jude Medical, and has received payment for the development of educational material from Allergan, Merck Sharpe, Dohme Ltd, and Medtronic.

Similar articles

Cited by

References

    1. Headache Classification Committee of the International Headache S The International Classification of Headache Disorders, 3rd edition (beta version) Cephalalgia. 2013;33:629–808. doi: 10.1177/0333102413485658. - DOI - PubMed
    1. May A, Leone M, Afra J, Linde M, Sandor PS, Evers S, et al. EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol. 2006;13:1066–1077. doi: 10.1111/j.1468-1331.2006.01566.x. - DOI - PubMed
    1. Pareja JA, Alvarez M. The usual treatment of trigeminal autonomic cephalalgias. Headache. 2013;53:1401–1414. - PubMed
    1. Costa A, Pucci E, Antonaci F, Sances G, Granella F, Broich G, et al. The effect of intranasal cocaine and lidocaine on nitroglycerin-induced attacks in cluster headache. Cephalalgia. 2000;20:85–91. doi: 10.1046/j.1468-2982.2000.00026.x. - DOI - PubMed
    1. Matharu MS, Levy MJ, Meeran K, Goadsby PJ. Subcutaneous octreotide in cluster headache: randomized placebo-controlled double-blind crossover study. Ann Neurol. 2004;56:488–494. doi: 10.1002/ana.20210. - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources